Greenhaven Associates

Edgar Wachenheim III serves as Chairman and Chief Executive Officer, and he has been the architect of the firm's investment strategy since founding it in 1987. He is the primary decision-maker on portfolio composition, drawing on a deep-value framework he detailed in his 2017 book, Common Stocks and Common Sense. The firm does not openly publicize a large investment committee structure, reflecting its centralized, conviction-driven approach.

Idea generation is traditional and fundamentally driven. Wachenheim has described a process of screening for companies trading at low multiples of earnings, cash flow, or book value, often following a period of severe negative sentiment. The firm does not rely on proprietary algorithms or high-frequency data; it uses publicly available financial statements and industry research. The ultimate filter is Wachenheim's own judgment on whether the business can normalize earnings through a full economic cycle.

Greenhaven Associates is a registered investment adviser structured as an independent asset management firm, not a single family office. It manages capital for a limited number of institutional clients and wealthy individuals. The firm does not disclose its client roster publicly, but its 13F filings confirm it invests as a single entity rather than through a family office structure.

Greenhaven invests exclusively in publicly traded equities and does not make private fund commitments or direct private equity investments. The firm's regulatory filings show a pure long-only approach to common stocks listed on U.S. exchanges. There is no evidence of the firm allocating to third-party hedge funds or venture funds.

As a public equity investor, Greenhaven does not target specific private-market stages. In the public markets, it often invests in mature, cyclical companies that are temporarily out of favor. Wachenheim has shown a preference for companies with strong market positions in beaten-down industries such as homebuilding, pulp-and-paper, and heavy equipment, which are later-stage in their corporate lifecycle.

Historically, the firm has shown little appetite for early-stage technology, biotechnology, or any business where earnings are not clearly visible in the near term. Wachenheim's book emphasizes the importance of current earnings power and tangible assets, which effectively screens out pre-revenue sectors. The firm has also typically avoided overvalued consumer staples and utility stocks during periods of extreme multiple expansion.

Wachenheim's stated philosophy is to use significant price declines to increase the position size, provided the original investment thesis remains intact. In his book, he details holding a major homebuilder through a 70% decline during the financial crisis, and then buying more. This high-conviction, anti-cyclical behavior is unusual in a world where most managers have institutional constraints that force them to trim losing positions.